A retrospective analysis of inotuzumab ozogamicin usage in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
The real-world study (RWS) highlights the effectiveness of InO in achieving remission and MRD negativity in R/R B-cell ALL, although treatment-related toxicities remain a concern.
Authors
- Arijit Nag (ORCID: https://orcid.org/0000-0002-2120-9570)
- Rahul Bhargava (ORCID: https://orcid.org/0000-0003-2801-540X)
- ChandranK Nair
- Pavan Kumar Boyella
Institutions
- Malabar Cancer Centre (IN)
- Tata Medical Center (IN)
- Rajiv Gandhi Cancer Institute and Research Centre (IN)
- Basavatarakam Indo American Cancer Hospital and Research Institute (IN)
- Fortis Memorial Research Institute (IN)
- Cancer Hospital and Research Institute (IN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-10
- DOI
- https://doi.org/10.3389/fonc.2025.1601782
- Citations
- 1
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 1.88